To include your compound in the COVID-19 Resource Center, submit it here.

Onercept: Phase II

In a double-blind, 12-week European Phase II study in 130 patients, 23 of 43 patients who received

Read the full 171 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE